Plain-English translation of NCT05715697 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing renal denervation—a procedure that blocks certain nerves in your kidneys—as a treatment for a specific type of heart failure called heart failure with preserved ejection fraction (HFpEF). People with HFpEF have hearts that pump normally but don't relax properly, and many also have high blood pressure that doesn't respond well to medicines. Researchers believe this nerve-blocking procedure might help improve symptoms and reduce the strain on your heart.
While doctors have effective treatments for some types of heart failure, HFpEF remains very difficult to treat, and current medicines only manage symptoms rather than address the underlying problem. This trial exists because scientists believe blocking these kidney nerves might help the heart relax better and reduce harmful stress in the body, offering a new hope for patients who haven't benefited enough from standard medications.
You will be randomly assigned to either receive the renal denervation procedure right away or receive a sham (fake) procedure as the control. Both groups will continue taking their regular heart failure medications. If you receive the sham procedure, after 1 year you will be offered the real procedure. The study will track your symptoms, heart function, and blood pressure over time through follow-up visits. The trial aims to enroll 200 participants across multiple hospitals in China.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
China